BioStock: Respiratorius raises 45 MSEK and prepares COPD project spinoff

Lund-based Respiratorius has announced carrying out a fully guaranteed rights issue to raise 45 MSEK. A majority of the capital will be allocated to finance the continued development of the COPD project RCD405, as the company eyes spinning off the project. Another large part of the funds will go towards preparing for an upcoming phase III study with VAL001 for the treatement of diffuse large-cell B-cell lymphoma, as the company gears up for selling the project.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/02/respiratorius-raises-45-msek-and-prepares-copd-project-spinoff/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se